38110/28.5.2012 Clinical Studies: 1st Clinical Study for the Treatment of Idiopathic Tinnitus by the ENT Clinic of Tzaneio 2nd Clinical Study for the Treatment of Idiopathic Tinnitus by the ENT Clinic of Tzaneio Preliminary Study by the ENT and Psychiatric Clinic of the General Hospital of Ionia - Patision & Hygeia Hospital Dietary supplements are not a substitute for a balanced diet
doi: 10.1021/jf4044056 245 WidjajaGRudiansyahMSultanMQAnsariMJIzzatSEAl JaberMSet al
1998;70(3 suppl 1):S12
doi: 10.1172/JCI113450 110 NorrelundHFrystykJJorgensenJOMollerNChristiansenJSOrskovHet al
Thus, in a first aspect, the invention relates to a method for the diagnosis of an adrenoleukodystrophy in a subject comprising determining in a sample from said subject a value selected from the group consisting of the levels of sphingosine-1-phosphate, the expression levels of sphingosine kinase 2, the expression levels sphingosine-1-phosphate receptor, the expression levels of adiponectin, the levels of at least one marker as defined in Table 1, the levels of at least one marker as defined in Table 2, the levels of at least one marker as defined in Table 3, the levels of at least one marker as defined in Table 4, the expression levels of at least one marker as defined in Table 5, the levels of at least one marker as defined in Table 6, the expression levels of at least one marker as defined in Table 7 and the expression levels of at least one marker as defined in Table 8 wherein increased levels of sphingosine-1-phosphate, increased levels of sphingosine kinase 2, increased levels of sphingosine-1-phosphate receptor, decreased expression levels of adiponectin, increased levels of at least one marker as defined in Table 1, decreased levels of at least one marker as defined in Table 2, increased levels of at least one marker as defined in Table 3, decreased levels of at least one marker as defined in Table 4, increased expression levels of at least one marker as defined in Table 5, increased levels of at least one marker as defined in Table 6, increased expression levels of at least one marker as defined in Table 7, and/or increased expression levels of at least one marker as defined in Table 8 with respect to a reference value are indicative that the subject suffers from an adrenoleukodystrophy
